Evidence map›Paper›PMID 40093847›Full record

ReviewDiscoveries (Craiova, Romania)

Recent Vaccines against Emerging and Tropical Infectious Diseases.

Ismail Mazhar, Mir Muhammad Rai, Abdullah Ahmad, Natasha Nadeem, Aamir Shahid Javed, Hassan Mumtaz

Abstract readReview
In one paragraph

Review in Discoveries (Craiova, Romania). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ismail MazharDepartment of Medicine, CMH Lahore Medical College and Institute of Dentistry, Lahore, Pakistan.
Mir Muhammad RaiDepartment of Medicine, CMH Lahore Medical College and Institute of Dentistry, Lahore, Pakistan.
Abdullah AhmadDepartment of Medicine, CMH Lahore Medical College and Institute of Dentistry, Lahore, Pakistan.
Natasha NadeemDepartment of Medicine, CMH Lahore Medical College and Institute of Dentistry, Lahore, Pakistan.
Aamir Shahid JavedDepartment of Medicine, CMH Lahore Medical College and Institute of Dentistry, Lahore, Pakistan.
Hassan MumtazDepartment of Data Analytics, BPP University London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Emerging diseases, re-emerging diseases and tropical diseases are a slowly progressing problem globally. This may in part be the result of shifting population, growing poverty, inadequate distribution of resources, or even complacency against personal hygiene. As a result of the low income and low standards of health in developing countries, they provide the perfect breeding grounds for the pathogens and parasites that are the root cause of Neglected Tropical diseases (NTDs). In the case of emerging diseases, most are of zoonotic origin and the recent COVID-19 pandemic is a key example. However, it is not just new diseases but re-emerging diseases such as Influenza that highlight the relentless nature of these infections. Vaccines represent the ultimate safety net against these diseases by bolstering immune systems and lowering subsequent mortality and morbidity of these conditions. In fact, against diseases with high mortalities such as AIDS, Hepatitis, and Malaria, vaccine development has markedly reduced mortality and prolonged life expectancy of those afflicted with these conditions. However, this research highlights the importance of enhancing vaccine efficacy and response. The review further underscores the necessity of research, the timing of vaccine administration, effective resource management by governments, and the perception of the population. Therefore, the review offers valuable insights for the medical community and the pharmaceutical industry in improving research and management to maximize the potential of vaccines.

Indexed as

diseases.emergingtropicalVaccines

Identifiers

PMID40093847
PMCPMC11910014

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.